Article Information
History
- April 26, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aleksandra Petrovic Fabijan1,2,+,
- Ruby CY Lin1,2,3,4,+,
- Josephine Ho1,2,
- Susan Maddocks1,2,3,
- Jonathan R Iredell1,2,3,*,
- on behalf of the Westmead Bacteriophage Therapy Team (WBTT),
- AmpliPhi Biosciences Corporation
- 1Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research (WIMR), Sydney, Australia
- 2Westmead Hospital, Western Sydney Local Health District (WSLHD), Sydney, Australia
- 3School of Medicine, Sydney Medical School, University of Sydney, Australia
- 4School of Medical Sciences, University of New South Wales, Australia
- 5Department of Cardiothoracic Surgery, Westmead Hospital, WSLHD, Sydney, Australia
- 6AmpliPhi BioSciences Corporations (APHB), Sydney, Australia
- 7AmpliPhi BioSciences Corporations, San Diego, CA, USA
- ↵*Correspondence: Jonathan Iredell, T: (61-2) 8890 6012/ 8627 3411, F: (61-2) 9891 5317, E: jonathan.iredell{at}sydney.edu.au
↵+ equal first author